AMANDA SCHULTZ: Open Payments
NPI 1932562097 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 41 payments from 13 companies in 2025. Trend: 2023 $893 · 2024 $1,049 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $165 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Alnylam Pharmaceuticals Inc. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| PFIZER INC. | 4 | $72 |
| Kestra Medical Technology Services, Inc. | 1 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novo Nordisk Inc | 2 | $51 |
| Abbott Laboratories | 1 | $48 |
| BridgeBio Pharma, Inc. | 2 | $46 |
Products named: REPATHA, LEQVIO, ONPATTRO, Assure WCD, CAMZYOS, Wegovy, AVEIR, Attruby.
Industry payments across FL — which companies pay providers there.
